Phase
Condition
N/ATreatment
Semaglutide J
Semaglutide B
Semaglutide N
Clinical Study ID
Ages 18-64 Male Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Male.
Age 18-64 years (both inclusive) at the time of signing the informed consent.
Body mass index (BMI) between 22.0 and 31.9 kilogram per square meter (kg/m^2) (bothinclusive) at screening.
Considered to be generally healthy based on the medical history, physicalexamination, and the results of vital signs, electrocardiogram (ECG) and clinicallaboratory tests performed during the screening visit, as judged by theinvestigator.
Exclusion
Exclusion Criteria:
Known or suspected hypersensitivity to study interventions or related products.
Any condition which in the investigator's opinion might jeopardise participant'ssafety or compliance with the protocol.
Use of prescription medicinal products or non-prescription drugs, except routinevitamins, topical medication not reaching the systemic circulation and occasionaluse of paracetamol (acetaminophen) and ibuprofen, within 14 days prior to firstdosing.
Study Design
Connect with a study center
Altasciences
Montreal, Quebec H3P 3P1
CanadaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.